Skip to main content
Clinical Trials/NCT01945437
NCT01945437
Unknown
Not Applicable

Magnesium and TKA Pain

Seoul National University Bundang Hospital0 sites60 target enrollmentJanuary 2014
ConditionsPain
InterventionsMagnesium Sulfate

Overview

Phase
Not Applicable
Intervention
Magnesium Sulfate
Conditions
Pain
Sponsor
Seoul National University Bundang Hospital
Enrollment
60
Primary Endpoint
Pain
Last Updated
12 years ago

Overview

Brief Summary

The hypothesis of this study is that in staged bilateral total knee arthroplasty (TKA, magnesium sulfate administered during the perioperative period of the first TKA may decrease pain after the second TKA. It is known that pain is greater in the second TKA than in the first. Therefore, we compared pain of the second TKA between the magnesium and control groups.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
December 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kim Mihyun

Doctor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • American society of anesthesiologist physical status 1 -
  • patients scheduled to undergo staged bilateral TKA

Exclusion Criteria

  • American society of anesthesiologist physical status \>3

Arms & Interventions

magnesium

This group receive magnesium sulfate perioperatively.

Intervention: Magnesium Sulfate

Outcomes

Primary Outcomes

Pain

Time Frame: from the end of the TKA until 48 hour

Pain measured with visual analogue scale (VAS)

Secondary Outcomes

  • analgesic(from the end of the TKA until 48 hours)

Similar Trials